ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10

FDA recall notice · announced December 13, 2023 · Wells Pharma Of Houston

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10

Reason for recall

Lack of assurance of sterility.

Notes

Distribution: Philadelphia, Pennsylvania.
Lot/code information: Lot # 11092313110#01, Exp 01/12/24
Quantity: 825 syringes
Status: Completed
Products in this recall event:
- ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10 (D-0141-2024)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.